INNT
TOTAL INVALIDATION PROCESSED BY THE IB
04/02/2026
Back to search
Official data from USPTO
VIFOR PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000079204052Class
3, 5, 41, 42, 44
Filing
79204052
Registration
5499803
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
47
Latest update
04/03/2026
Trademark type
Combined
Nice classes
3, 5, 41, 42, 44
Filing date
02/06/2017
Registration date
06/26/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/10/2025
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
3
Owner type
25
Owner location
CH
Examiner
CARROLL, DORITT
Law office
M70
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the wording "VIFOR PHARMA" accompanied by a design of three concentric incomplete triangles.
Holders and representatives
Holders
Vifor (International) AG (Vifor (International) Ltd.) (Vifor (International) Inc.)
Representatives
Marie Anne Mastrovito Womble Bond Dickinson (US) LLP
Technical classification
Nice Classes
Class 3Class 5Class 41Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 3
Bleaching preparations for laundry use; cleaningpolishingabrasive preparations; degreasing preparations for household use; skin soaps; perfumeryessential oilscosmeticshair lotions; dentifrices
Class 5
Pharmaceutical or veterinary preparations for use in oncology and diabetes; pharmaceutical or veterinary preparations for the treatment or prevention of cardiovascularcirculatoryrenal systemkidneycardio-renalimmune systemgastroenterologicalgastrointestinalstomachdermatologicalhematologicalbonerespiratorygeneticallergicinflammationinfectiouspaincentral nervous systemendocrinologyhormonalmuscularrheumaticocular and metabolic diseases and disorders; pharmaceutical and veterinary preparations used as immune system stimulator; pharmaceutical preparations for the treatment or prevention of mineral deficiencies or mineral overload; pharmaceutical preparations for the treatment or prevention of metal deficiencies or metal overload; pharmaceutical preparations for the treatment or prevention of vitamin deficiencies or vitamin overloadvitamin and mineral supplementsvitamin preparations and mineral preparations for medical use; sanitary preparations for medical purposes; dietetic foods adapted for medical or veterinary use; food for babies; food supplements for humans and animals; medical plastersmedical dressings; material for dental fillings and dental impressions; disinfectants
Class 41
Education servicesnamely organization of seminars and workshops in the field of pharmaceutical preparations; training services in the field of pharmaceutical preparationsnamely medical and pharmaceutical training in the use and dispensing of pharmaceutical preparations and distributing printed course materials in conjunction therewith; providing on-line journalsblogs in the medicalpharmaceutical and health fields
Class 42
Research and development of new productspharmaceutical preparationsfor others; design and development of computers and software; scientific and technological services for othersnamely testing and developing of pharmaceutical preparations
Class 44
Medical services; veterinary services; hygienic and beauty care
Publications
History of USPTO decisions and trademark events.
47 publications found
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
02/14/2026
XXCR
GENERIC MADRID TRANSACTION CREATED
02/14/2026
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
09/10/2025
C71T
CANCELLED SECTION 71
01/10/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
06/26/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/24/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/24/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
10/24/2022
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
10/24/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/24/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/24/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/24/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/21/2021
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/23/2018
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
09/28/2018
XXCR
GENERIC MADRID TRANSACTION CREATED
09/28/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/26/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
06/26/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/10/2018
PUBO
PUBLISHED FOR OPPOSITION
04/10/2018
GPNX
NOTIFICATION PROCESSED BY IB
04/06/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/21/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/21/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/21/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/06/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
03/06/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/06/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
03/06/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/06/2018
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
11/21/2017
GNFR
FINAL REFUSAL E-MAILED
11/21/2017
CNFR
FINAL REFUSAL WRITTEN
11/21/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/28/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/27/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/27/2017
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/24/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/24/2017
RFNT
REFUSAL PROCESSED BY IB
05/20/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/04/2017
RFRR
REFUSAL PROCESSED BY MPU
05/04/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/02/2017
CNRT
NON-FINAL ACTION WRITTEN
05/01/2017
DOCK
ASSIGNED TO EXAMINER
05/01/2017
MAFR
APPLICATION FILING RECEIPT MAILED
04/04/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/31/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/30/2017
Continuous trademark protection
Get notified about every new filing that threatens VIFOR PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.